Valiant Organics Limited

15.62%

Margin (%) FY25 Revenue Break-up – Chemistries FY25 Revenue Break-up – End user Industry 10,518 15.62% 12 000 10 000 80 00 60 00 40 00 20 00 0 7,231 7,188 5.28% 7.47% 3,617 12.69% FY23 FY2

5.28%

p – End user Industry 10,518 15.62% 12 000 10 000 80 00 60 00 40 00 20 00 0 7,231 7,188 5.28% 7.47% 3,617 12.69% FY23 FY24 Revenue FY25 EBITDA Margin H1-FY26 50 .0 0% 45 .0 0% 40 .0 0

7.47%

user Industry 10,518 15.62% 12 000 10 000 80 00 60 00 40 00 20 00 0 7,231 7,188 5.28% 7.47% 3,617 12.69% FY23 FY24 Revenue FY25 EBITDA Margin H1-FY26 50 .0 0% 45 .0 0% 40 .0 0% 35 .

12.69%

y 10,518 15.62% 12 000 10 000 80 00 60 00 40 00 20 00 0 7,231 7,188 5.28% 7.47% 3,617 12.69% FY23 FY24 Revenue FY25 EBITDA Margin H1-FY26 50 .0 0% 45 .0 0% 40 .0 0% 35 .0 0% 30 .0 0%

0%

7,231 7,188 5.28% 7.47% 3,617 12.69% FY23 FY24 Revenue FY25 EBITDA Margin H1-FY26 50 .0 0% 45 .0 0% 40 .0 0% 35 .0 0% 30 .0 0% 25 .0 0% 20 .0 0% 15 .0 0% 10 .0 0% 5.00 % 0.00 % Ot

5.00 %

H1-FY26 50 .0 0% 45 .0 0% 40 .0 0% 35 .0 0% 30 .0 0% 25 .0 0% 20 .0 0% 15 .0 0% 10 .0 0% 5.00 % 0.00 % Others, 5% Chlorination, 20% Ammonolysis, 28% Hydrogenation, 47% Dyes & Pigments;

0.00 %

50 .0 0% 45 .0 0% 40 .0 0% 35 .0 0% 30 .0 0% 25 .0 0% 20 .0 0% 15 .0 0% 10 .0 0% 5.00 % 0.00 % Others, 5% Chlorination, 20% Ammonolysis, 28% Hydrogenation, 47% Dyes & Pigments; 52% Pha

rs,

45 .0 0% 40 .0 0% 35 .0 0% 30 .0 0% 25 .0 0% 20 .0 0% 15 .0 0% 10 .0 0% 5.00 % 0.00 % Others, 5% Chlorination, 20% Ammonolysis, 28% Hydrogenation, 47% Dyes & Pigments; 52% Pharmaceutica

5%

0 0% 40 .0 0% 35 .0 0% 30 .0 0% 25 .0 0% 20 .0 0% 15 .0 0% 10 .0 0% 5.00 % 0.00 % Others, 5% Chlorination, 20% Ammonolysis, 28% Hydrogenation, 47% Dyes & Pigments; 52% Pharmaceuticals

20%

.0 0% 30 .0 0% 25 .0 0% 20 .0 0% 15 .0 0% 10 .0 0% 5.00 % 0.00 % Others, 5% Chlorination, 20% Ammonolysis, 28% Hydrogenation, 47% Dyes & Pigments; 52% Pharmaceuticals; 13% Specialty C

28%

.0 0% 20 .0 0% 15 .0 0% 10 .0 0% 5.00 % 0.00 % Others, 5% Chlorination, 20% Ammonolysis, 28% Hydrogenation, 47% Dyes & Pigments; 52% Pharmaceuticals; 13% Specialty Chemicals; 10% Agro

47%

.0 0% 10 .0 0% 5.00 % 0.00 % Others, 5% Chlorination, 20% Ammonolysis, 28% Hydrogenation, 47% Dyes & Pigments; 52% Pharmaceuticals; 13% Specialty Chemicals; 10% Agro Chemicals; 25% *P

“• • Dyes Pigments H1-FY26 Revenue Share 50% 4 25% Hydrogenation Ortho Anisidine Para Anisidine IPPCA”

“Q2-FY26 Revenue Break-up – Chemistries Others, 6% • Gross Profit came in at INR 718 million, with gross margin improving sharply to 46% (versus 39% in Q1 FY26 and 36% in Q2 FY25), supported by better raw-material efficiency and an improved product mix.”

“H1-FY26 Volume Break-up – Chemistries Others, 2% PAT stood at INR 56 million, marking a strong recovery from the loss reported in Q2 FY25.”

Key Products

6

Industries Served

6

Sub

1

Valorem Advisors Disclaimer

1

Sub

Investors' Presentation. To, Listing / Compliance Department National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai- 400 051. SYMBOL- VALIANTORG Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Investors’ Presentation for Q2 FY 2025-26 Results of Valiant Organics Limited (the “Company”). A copy of aforesaid www.valiantorganics.com Investors' Presentation is also hosted on the website of Company Please take the same on your records. Thanking you, Yours faithfully, For Valiant Organics Limited Kaustubh Kulkarni Company Secretary ICSI Mem No: A52980 Regd. Office:109, Udyog Kshetra, 1st Floor, Mulund Goregaon Link Rd, Mulund West, Mumbai 400080, India. +91 22 6797 6683 • info@valiantorganics.com • www.valiantorganics.com CIN NO.: L24230MH2005PLC151348 E a r n i n g s P r e s e n t a t i o n | Q 2 / H 1 - F Y 2 6 SNAPSHOT One of the largest

Key Products

• • • • • Para ChloroPhenol (PCP) Ortho ChloroPhenol (OCP) 2,4 Di Chlorophenol (2,4 DCP) 2,6 Di ChloroPhenol (2,6 DCP) 2,4,6 Tri ChloroPhenol (2,4,6 TCP)

Industries Served

• Agro Chemicals • Cosmetics • Veterinary • Pharmaceuticals Valiant Organics Limited | Q2-2026 4 Manufacturing Footprint CHLORINATION – SARIGAM • Capacity: 18,000 MTPA • Products: PCP, OCP, 2,4 DCP, 2,6 DCP, 2,4,6 TCP AMMONOLYSIS - VAPI • • Capacity: 10,000 MTPA Products: PNA, OCPNA AMMONOLYSIS - TARAPUR • Capacity: 6,600 MTPA • Products: PNA HYDROGENATION & METHOXYLATION- JHAGADIA UNIT 1 • • Capacity: 28,800 MTPA Products: ONA/OA, PNA/PA, IPPCA, CONVERSION PRODUCTS HYDROGENATION – JHAGADIA UNIT 2 • • Capacity: 12,000 MTPA Products: PAP, PHARMA INTERMEDIATES ACETYLATION & SULPHONATION – AHMEDABAD • • Capacity: 1,800 MTPA Products: 6 ACETYL OAPSA, OA/PA ACETANILIDE, OT5SA Valiant Organics Limited | Q2-2026 5 Key Strengths Domain expertise and broad process understanding in a variety of chemistries. The executive team is made up of first-generation technocrats with more than 50 years of collective expertise. Wide supply chain provides the continuous availability of adequate and high-qual

Valorem Advisors Disclaimer

Valorem Advisors is an Independent Investor Relations Management Service company. This Presentation has been prepared by Valo rem Advisors based on information and data which the Company considers reliable, but Valorem Advisors and the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall b e placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may conside r material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Valorem Advisors also hereby certifies that the directors or employees of Valorem Advisors do not own any stock in personal or company capacity of the Company under review. For further details please contact our Investor Relations Representatives: VALOREM ADVISORS Mr. Anuj Sonpal Tel: +91-22-49039500 Email: valiant@valor